Pronostic, life expectancy, quality of life, ..... in chronic myeloid leukemia - CML
The life expectancy of patients treated for chronic myeloid leukemia (CML) approaches the life expectancy of the general population. The quality of life is good for the majority of the CMLers.
VIDEOS
Meeting the New Challenges in CML Therapy with Dr. Brian Druker * must be seen *
December 2, 2016, iCMLf forum
Meeting the New Challenges in CML Therapy with Dr. Brian Druker * must be seen *
December 2, 2016, iCMLf forum
ARTICLES
Loss in Overall and Quality-Adjusted Life Expectancy for Patients With Chronic-Phase Chronic Myeloid Leukemia
November 6, 2024, European Journal of Haematology
The loss of life expectancy in patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2018
June 11, 2021, EHA Library
Stopping TKI Treatment Is Safe, Improves Quality of Life for Some with CML
December 15, 2020, National Cancer Institute
Do persons with chronic myeloid leukaemia have normal or near normal survival?
December 20, 2019, Leukemia
An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States
August 19, 2019, PubMed
Health-Related Quality of Life and Symptom Burden in Chronic Myeloid Leukemia Patients Treated with First Line with Imatinib Versus Those Treated with Dasatinib: First Results of the Leonidas Study
December 2017, ASH 2017
Survival of Chronic Myeloid Leukemia Patients in Comparison to General Population in the Tyrosine Kinase Inhibitors Era: A US Population Based Study
December 2017, ASH 2017
Long-Term Survival of Patients with Chronic Phase Chronic Myeloid Leukemia Who Received Autologous Stem Cell Transplantation and Further Exposed to Tyrosine Kinase Inhibitors. a Study on Behalf of the French Society of Blood and Marrow Transplantation and the French Group of CML
December 2017, ASH 2017
CML Patients Approach Normal Life Expectancy With Imatinib Treatment
July 21, 2017, Cancer Network Hematology
The survivors: How an experimental treatment saved patients and changed medicine
April 25, 2017, STAT
100 Years of Chronic Myeloid Leukemia Prevalence in France
December 2016, Journal Blood
Life Span of CML Patients Approaches Usual Limits
June 28,2016, Medscape
Life Expectancy in CML Patients Approaching General Population's
June 24,2016, Cancer Network
Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
June 20, 2016, Journal of Clinical Oncology
CML No Longer Spells Early Death
June 20, 2016, MedPage Today
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
February 26, 2016, Leukemia
Chronic Myeloid Leukemia Prognosis and Your Life Expectancy
January 12, 2015, Healthline
Chronic Myeloid Leukemia Patients On Kinase Inhibitors Report Serious Quality-Of-Life Issues
June 12, 2013, MedicalNewsToday
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population.
October 27, 2011, PubMed
Long-term estimate of quality-adjusted life expectancy for nilotinib and imatinib as first-line treatment for newly diagnosed patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia in the chronic phase (CML-CP).
June 2011, 2011 ASCO Annual Meeting
CML Patients Taking Imatinib Have Similar Mortality Rates to People in General Population - Pronostic
March 23, 2011, Journal of the National Cancer Institute
Living With a Formerly Fatal Blood Cancer
January 18, 2010, The New York Times
Loss in Overall and Quality-Adjusted Life Expectancy for Patients With Chronic-Phase Chronic Myeloid Leukemia
November 6, 2024, European Journal of Haematology
The loss of life expectancy in patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2018
June 11, 2021, EHA Library
Stopping TKI Treatment Is Safe, Improves Quality of Life for Some with CML
December 15, 2020, National Cancer Institute
Do persons with chronic myeloid leukaemia have normal or near normal survival?
December 20, 2019, Leukemia
An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States
August 19, 2019, PubMed
Health-Related Quality of Life and Symptom Burden in Chronic Myeloid Leukemia Patients Treated with First Line with Imatinib Versus Those Treated with Dasatinib: First Results of the Leonidas Study
December 2017, ASH 2017
Survival of Chronic Myeloid Leukemia Patients in Comparison to General Population in the Tyrosine Kinase Inhibitors Era: A US Population Based Study
December 2017, ASH 2017
Long-Term Survival of Patients with Chronic Phase Chronic Myeloid Leukemia Who Received Autologous Stem Cell Transplantation and Further Exposed to Tyrosine Kinase Inhibitors. a Study on Behalf of the French Society of Blood and Marrow Transplantation and the French Group of CML
December 2017, ASH 2017
CML Patients Approach Normal Life Expectancy With Imatinib Treatment
July 21, 2017, Cancer Network Hematology
The survivors: How an experimental treatment saved patients and changed medicine
April 25, 2017, STAT
100 Years of Chronic Myeloid Leukemia Prevalence in France
December 2016, Journal Blood
Life Span of CML Patients Approaches Usual Limits
June 28,2016, Medscape
Life Expectancy in CML Patients Approaching General Population's
June 24,2016, Cancer Network
Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
June 20, 2016, Journal of Clinical Oncology
CML No Longer Spells Early Death
June 20, 2016, MedPage Today
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
February 26, 2016, Leukemia
Chronic Myeloid Leukemia Prognosis and Your Life Expectancy
January 12, 2015, Healthline
Chronic Myeloid Leukemia Patients On Kinase Inhibitors Report Serious Quality-Of-Life Issues
June 12, 2013, MedicalNewsToday
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population.
October 27, 2011, PubMed
Long-term estimate of quality-adjusted life expectancy for nilotinib and imatinib as first-line treatment for newly diagnosed patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia in the chronic phase (CML-CP).
June 2011, 2011 ASCO Annual Meeting
CML Patients Taking Imatinib Have Similar Mortality Rates to People in General Population - Pronostic
March 23, 2011, Journal of the National Cancer Institute
Living With a Formerly Fatal Blood Cancer
January 18, 2010, The New York Times
